BUILD A HEART SAVE A LIFE
Investor Update!!
|
BIOLIFE4D is very excited to announce that we have already achieved incredible progress in our labs, we are more than a year ahead of initial time projections after only 4 months, AND we have also surpassed $1 million dollars of stock sold in our equity crowdfunding event. As a result of these incredible achievements we can also report that as of June 22nd, 2018 the share price of our stock has already reached $12 per share - a 20% increase in only 4 months. We appreciate the incredible support from all our dedicated investors. |
By Emilia Benton, Correspondent Updated 10:11 am CDT, Tuesday, October 23, 2018 According to U.S. Government Information on Organ Donation and Transplantation, hundreds of thousands of patients across the U.S. are currently on a waiting list for a transplanted organ, and 20 people die each day waiting for a transplant. However, researchers within the Texas Medical Center…
Pioneering biotech company reaches significant milestone well ahead of 6-8 month development time, successfully 3D bioprinting a human cardiac patch, as it seeks to produce full human hearts viable for transplant CHICAGO – June 25, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today…
Less than six months ago we announced our residency at the Johnson & Johnson Innovation JLABS at the renowned Texas Medical Center in Houston, Texas. Since that time, through the access of state-of-the-art equipment and support, we have been able to accelerate our scientific roadmap, successfully 3D bioprinting a human cardiac patch significantly ahead of schedule. Following…
